류마티스 관절염에서 광금전초 추출물의 관절염 억제 효과
Extracts of Desmodii Herba Suppresses of Rheumatoid Arthritis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Desomodii Herba (DH) has been shown to exhibit pharmacologyical activities, such as increase myocaridal contraction and secretion of hepatic bile. DH is used to reduce pain caused by rheumatoid arthritis(RA) in Korean medicine. However, the DH exact(DHE) effect and mechanism on rheumatoid arthritis are unknown. In this study, we aimed at the inhibitory effect of DHE on rheumatoid arthritis, and investigated the effect in collagen-induced mice arthritis model and TNF-αinduced MMP-1 and MMP-3 expression including the molecular basis in rheumatoid arthritis synovial fibroblasts (RASFs).The effect of DHE on RA was measured by clinical scoring system. In RASFs, expression of MMP-1 and MMP-3 was assessed by Western blotting and real-time PCR. Also, Western blotting used to evaluate the phosphorylation levels of p38, ERK and JNK and activation of NF-κB and AP-1. Our results showed that DHE reduced collagen-induced arthritis in mice. DHE inhibits TNF-αinduced MMP-1 and MMP-3 expression and mRNA levels in RASFs. The inhibitory effect of DHE was mediated by the inhibition of the AP-1/JNK signaling pathway. Taken together, our results suggest that the DHE may have preventive potential for rheumatoid arthritis.
Abstract
Desomodii Herba (DH) has been shown to exhibit pharmacologyical activities, such as increase myocaridal contraction and secretion of hepatic bile. DH is used to reduce pain caused by rheumatoid arthritis(RA) in Korean medicine. However, the DH exact(DHE) effect and mechanism on rheumatoid arthritis are unknown. In this study, we aimed at the inhibitory effect of DHE on rheumatoid arthritis, and investigated the effect in collagen-induced mice arthritis model and TNF-αinduced MMP-1 and MMP-3 expression including the molecular basis in rheumatoid arthritis synovial fibroblasts (RASFs).The effect of DHE on RA was measured by clinical scoring system. In RASFs, expression of MMP-1 and MMP-3 was assessed by Western blotting and real-time PCR. Also, Western blotting used to evaluate the phosphorylation levels of p38, ERK and JNK and activation of NF-κB and AP-1. Our results showed that DHE reduced collagen-induced arthritis in mice. DHE inhibits TNF-αinduced MMP-1 and MMP-3 expression and mRNA levels in RASFs. The inhibitory effect of DHE was mediated by the inhibition of the AP-1/JNK signaling pathway. Taken together, our results suggest that the DHE may have preventive potential for rheumatoid arthritis.
참고문헌 (27)
- Pap T, "Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis", Arthritis Res, 2, pp.361~367 (2000)
- Yoshihara Y, "Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis", Ann Rheum Dis, 59, pp.455~464 (2000)
- Aviña-Zubieta JA, "Risk of cardiovascular mortality in patients with rheumatoid arthritis : a meta-analysis of observational studies", Arthritis Rheum, 59, pp.1690~1697 (2008)
- Crisp AJ, "Rheumatoid lung disease, pneumothorax, and eosinophilia", Ann Rheum Dis, 41, pp.137~140 (1982)
- Joana FF, "Glucocorticoids and Rhematoid Arthritis", Rheum dis Clin North Am, 42, pp.33~46 (2016)
- Taukumova LA, "Mucocutaneous side effects and continuation of aurotherapy in patients with rheumatoid arthritis", Adv Exp Med Biol, 455, pp.367~373 (1999)
- Kim YJ, "Inflammation in methotraexate-induced pulmonary toxicity occurs via the p38 MAPK pathway", Toxicology, 256, pp.183~190 (2009)
- Konttinen TY, "Analysis of 16 different matrix metallo proteinases(MMP-1 to MMP-20)in the synovial membrane : different profiles in trauma and rheumatoid arthritis", Ann Rheum Dis, 58, pp.691~697 (1999)
- Jackson C, "Selective matrix metalloproteinase (MMP) inhibition in rheumatoid arthritis-targetting gelatinase A activation", Inflamm Res, 50, pp.183~186 (2001)
- Feldmann M, "Role of cytokines in rheumatoid arthritis", Annu Rev Immunol, 14, pp.397~440 (1996)
- Noh EM, "Cordycepin inhibits IL-1β-induced MMP-1 and MMP-3 expression in rheumatoid arthritis synovial fibroblasts", RHEUMATOLOGY, 48, pp.45~48 (2009)
- Kim CM, "Great Dictionary of chinese Medicine", pp.369~371 (1999), Junngdam
- 황진기, "유방암세포에서 광금전초 추출물의 암전이 억제 효과", 동의생리병리학회지, 28(5), pp.494~498 (2014), 한의병리학회
- Hwang JK, "Emodin suppresses inflammatory responses and joint destruction in collagen-induced arthritic mice", Rheumatology, 52, pp.1583~1591 (2013)
- Pretzel D, "In vitro model for the analysis of synovial fibroblast-mediated degradation of intact cartilage", Arthritis Res Ther, 11, pp.R25~ (2009)
- Rooney T, "Synovial tissue and serum biomarkers of disease activiy, therapeutic response and radiographic progression : analysis of a proof-of-concept randomised clinical trial of cytokine blockade", Ann Rheum Dis, 69, pp.706~714 (2010)
- Paunovic V, "Mitogen-activated protein kinases as therapeutic targets for rheumatoid arthritis", Drgus, 73, pp.101~115 (2013)
- Filipovic I, "Quantifying the economic burden of productivity loss in rheumatoid arthritis", RHEUMATOLOGY, 50, pp.1083~1090 (2011)
- Zhao S, "Complementary and alternative medicine use in Rheumatoid arthritis : Considerations for the pharmacological management of elderly patients", Drugs Aging, 34, pp.255~264 (2017)
- Kolasinski SL, "Herbal medicine for rheumatic diseases: promises kept?", Curr Rheumatol Rep, 14, pp.617~623 (2012)
- "한국전통지식포탈의 약재/처방/병증 DB"[URL]
- Georg S, "Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-jun N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis", Arthritis Rheumatol, 43, pp.2501~2512 (2000)
- Lindsey AM, "Kinase inhibitors: The next generation of therapies in the treatment of rhumatoid arthritis", Int J Rheum. Dis, 17, pp.359~368 (2014)
- Verica P, "Mitogen-Activated Protein kinases as therapeutic targets for rheumatoid arthritis", Drugs, 73, pp.101~115 (2013)
- Abdelhamid L, "Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1(AP-1)and nuclear factor kappa B(NF-kB)transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes", Matrix Biol, 23, pp.251~262 (2002)
- Jacques M, "Signal transduction pathways : new targets for treating rheumatoid arthritis", Joint Bone Spine, 71, pp.503~510 (2004)
- Francois R, "Cartilage breakdown in rheumatoid arthritis", Joint Bone Spine, 73, pp.29~36 (2006)